Establishing Pompe Disease Newborn Screening: The Role of Industry
Open Access
- 5 July 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Neonatal Screening
- Vol. 6 (3), 55
- https://doi.org/10.3390/ijns6030055
Abstract
When clinical trials for enzyme replacement therapy for Pompe disease commenced, a need for newborn screening (NBS) for Pompe disease was recognized. Two methods for NBS for Pompe disease by measuring acid α-glucosidase in dried blood spots on filter paper were developed in an international collaborative research effort led by Genzyme. Both methods were used successfully in NBS pilot programs to demonstrate the feasibility of NBS for Pompe disease. Since 2009, all babies born in Taiwan have been screened for Pompe disease. Pompe disease was added to the Recommended Uniform (Newborn) Screening Panel in the United States in 2015. NBS for Pompe disease is possible because of the unprecedented and selfless collaborations of countless international experts who shared their thoughts and data freely with the common goal of establishing NBS for Pompe disease expeditiously.This publication has 16 references indexed in Scilit:
- A Tandem Mass Spectrometry Triplex Assay for the Detection of Fabry, Pompe, and Mucopolysaccharidosis-I (Hurler)Clinical Chemistry, 2010
- Development and Evaluation of Quality Control Dried Blood Spot Materials in Newborn Screening for Lysosomal Storage DisordersClinical Chemistry, 2009
- Multiplex Enzyme Assay Screening of Dried Blood Spots for Lysosomal Storage Disorders by Using Tandem Mass SpectrometryClinical Chemistry, 2008
- Early Detection of Pompe Disease by Newborn Screening Is Feasible: Results From the Taiwan Screening ProgramPEDIATRICS, 2008
- Methods for a prompt and reliable laboratory diagnosis of Pompe disease: Report from an international consensus meetingMolecular Genetics and Metabolism, 2008
- Rapid diagnosis of late-onset Pompe disease by fluorometric assay of α-glucosidase activities in dried blood spotsMolecular Genetics and Metabolism, 2007
- Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid α-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe diseaseGenetics in Medicine, 2006
- Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe diseaseMolecular Genetics and Metabolism, 2005
- Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn ScreeningClinical Chemistry, 2004
- Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paperClinica Chimica Acta; International Journal of Clinical Chemistry, 2004